ArticleTheranostics2020

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.

Tim Wilhelmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.